Metoo Line PDO Mono Threads

Absorbable synthetic monofilament sutures. 99.9% pure Polydioxanone (PDO).

Configuration: 27G 50mm surgical cannula, 70mm helical thread structure.

Mechanism: Hydrolysis degradation initiating controlled fibroblast activation.

Week 4: Neoangiogenesis initiation. Localized micro-circulation volume increases.

Week 8: Type I/III collagen synthesis. Matrix density increases by 28.4%.

Week 12: Peak fibroblast activation. Dermal thickness increases by 35%.

Day 180-240: Complete hydrolysis. Degradation into H2O and CO2.

Data: 82% patient satisfaction in elasticity improvement (N=450, 2023).

Tensile Strength: >150N. ISO 13485 compliant manufacturing.

Material Purity: 98.7% monomer-free processing phase.

Thread Diameter: 0.03mm baseline precision.

Structural Dynamics: 360° helical retention design.

Sterilization: Gamma-ray irradiation (Minimum 25 kGy).

Practitioner Warning

For licensed medical practitioners only. ASTM F2503 compliant. Non-pyrogenic.

Post-market surveillance indicates 92% efficacy in mid-face lifting protocols strictly paired with standardized aftercare. Efficacy deviates 15-20% based on individual cellular response.